Risk‐Based Colonoscopy Prioritization Model for Advanced Colorectal Neoplasia: Development and Validation Study
Journal of Gastroenterology and Hepatology · 2026
DOI: 10.1111/jgh.70360 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Journal of Gastroenterology and Hepatology, 2026. Verfasst von Chote Wongkanong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Pattani Hospital, Pattani, Thailand. Hauptthemen laut MEDLINE: Colonoscopy, Colorectal Neoplasms, Early Detection of Cancer. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: The Medical Council of Thailand.
Abstract (Originalsprache)
Background/Aims The incidence of colorectal cancer (CRC) keeps rising throughout Asia but validated models for predicting advanced colorectal neoplasia (ACN) in Thai populations are absent locally. Limited colonoscopy capacity highlights the need for precolonoscopy risk stratification. This study developed and validated a Thai‐specific prediction model of ACN in asymptomatic adults, aged ≥ 40 years, by utilizing routine clinical variables.
Methods
A retrospective cross‐sectional study was conducted at Pattani Hospital, Thailand (2020–2024). Adults aged ≥ 40 years undergoing colonoscopy were included and assigned to derivation ( n = 715) and temporal validation within a single center ( n = 659) cohorts. Seven clinical predictors—age, sex, body mass index, diabetes mellitus, smoking, alcohol use, and family history of CRC—were modeled using multivariable fractional–polynomial interaction (MFPI) logistic regression. Model performance was assessed using area under the receiver‐operating characteristic curve (AUC), calibration‐in‐the‐large (CITL), calibration slope, Brier score, and decision‐curve analysis (DCA).
Results
Among 1374 participants, 192 (13.9%) had ACN. The model achieved AUCs of 0.76 (95% CI 0.72–0.81) in the derivation cohort and 0.67 (95% CI 0.60–0.76) in the validation cohort, with calibration slope 0.76 and CITL 0.002. Bootstrap shrinkage was 0.94. DCA demonstrated consistent net benefit across risk thresholds of 7%–65%. Using a 12% risk cutoff, one ACN was detected for every three colonoscopies, reducing colonoscopy volume by 48.4%.
Conclusion
The Thai‐specific MFPI model demonstrates good calibration, temporal validation, and clinically meaningful utility. Its application may optimize colonoscopy allocation and strengthen precision precolonoscopy risk stratification in resource‐limited settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Pattani Hospital, Pattani, Thailand.
- Surgical Endoscopy Unit, Department of Surgery, Rajavithi Hospital, Department of Medical Services, Ministry of Public Health, Mueang Nonthaburi, Thailand.
- Clinical Epidemiology and Clinical Statistics Unit, Faculty of Medicine, Naresuan University, Phitsanulok, Thailand.
ORCID-Profile: Chote Wongkanong
Förderung
- The Medical Council of Thailand
Zitieren
APA
Wongkanong, C., Ratanachu-Ek, T., Salaeh, R., & Patumanond, J. (2026). Risk‐Based Colonoscopy Prioritization Model for Advanced Colorectal Neoplasia: Development and Validation Study. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.70360
Vancouver
Wongkanong C, Ratanachu-Ek T, Salaeh R, Patumanond J. Risk‐Based Colonoscopy Prioritization Model for Advanced Colorectal Neoplasia: Development and Validation Study. Journal of Gastroenterology and Hepatology. 2026. doi:10.1111/jgh.70360
BibTeX
@article{Wongkanong2026,
author = {Wongkanong, Chote and Ratanachu-Ek, Thawee and Salaeh, Rusta and Patumanond, Jayanton},
title = {Risk‐Based Colonoscopy Prioritization Model for Advanced Colorectal Neoplasia: Development and Validation Study},
journal = {Journal of Gastroenterology and Hepatology},
year = {2026},
doi = {10.1111/jgh.70360}
}
EUVIMED